News
VVOS
1.440
+6.67%
0.090
Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates
NASDAQ · 1d ago
Weekly Report: what happened at VVOS last week (0223-0227)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 6d ago
Weekly Report: what happened at VVOS last week (0216-0220)?
Weekly Report · 02/23 09:00
New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America
Barchart · 02/21 04:45
Vivos Therapeutics files to sell 3.96M shares of common stock for holders
TipRanks · 02/17 11:15
Weekly Report: what happened at VVOS last week (0209-0213)?
Weekly Report · 02/16 09:00
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST)
Barchart · 02/14 04:10
Vivos Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Director Gregg C. Johnson
Reuters · 02/14 01:37
Weekly Report: what happened at VVOS last week (0202-0206)?
Weekly Report · 02/09 09:00
Vivos Therapeutics Appoints Gregg Johnson to Board
TipRanks · 02/06 21:38
BUZZ-U.S. STOCKS ON THE MOVE-Netflix, FirstCash Holdings, CF Bankshares
Reuters · 02/05 18:48
BUZZ-U.S. STOCKS ON THE MOVE-OneSpaWorld, IMUNON, Cigna 
Reuters · 02/05 15:44
BUZZ-Vivos jumps as device maker partners with SoundHealth to broaden sleep, allergy offerings
Reuters · 02/05 13:54
Vivos, SoundHealth collaborate to expand access to SoundHealth’s technology
TipRanks · 02/05 13:50
Vivos Therapeutics signs 12-part media series with New to the Street
TipRanks · 02/05 13:50
Vivos Therapeutics And SoundHealth Collaborate To Advance Access To SoundHealth's Consumer-Focused Airway And Sleep Health Technologies
Benzinga · 02/05 13:48
Vivos Therapeutics Partners with SoundHealth to Expand Access to Sleep and Allergy Technologies
Reuters · 02/05 13:45
VIVOS THERAPEUTICS AND SOUNDHEALTH ANNOUNCE COLLABORATION TO EXPAND ACCESS TO SOUNDHEALTH’S GROUNDBREAKING FDA-CLEARED ALLERGY AND SLEEP TECHNOLOGIES
Reuters · 02/05 13:45
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 02/04 21:05
More
Webull provides a variety of real-time VVOS stock news. You can receive the latest news about Vivos Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About VVOS
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.